|
Limax marginatus
|
|
ILX:0106260
|
6
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limax maximus
|
|
ILX:0106261
|
6
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limb-girdle Muscular Dystrophy
|
All limb-girdle muscular dystrophies show a similar distribution of muscle weakness, affecting both upper arms and legs. Many forms of limb-girdle muscular dystrophy have been identified; some affect children, whereas others manifest in adulthood.
|
ILX:0106262
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limbic Encephalitis
|
A paraneoplastic syndrome marked by degeneration of neurons in the medial temporal lobe. Clinical features include behavioral changes, HALLUCINATIONS, loss of short term memory, anosmia, AGEUSIA, and DEMENTIA. Circulating anti-neuronal antibodies (anti-Hu; also called ANNA 1) and small cell lung carcinomas are frequently associated with this condition (MeSH).
|
ILX:0106263
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limbic lobe
|
Part of cerebral hemisphere located on the medial surface, forming a ring around the brain stem
|
ILX:0106264
|
12
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limbic system
|
A set of midline structures surrounding the brainstem of the mammalian brain, originally described anatomically, e.g., hippocampal formation, amygdala, hypothalamus, cingulate cortex. Although the original designation was anatomical, the limbic system has come to be associated with the system in the brain subserving emotional functions. As such, it is very poorly defined and doesn't correspond closely to the anatomical meaning any longer.
|
ILX:0106265
|
9
|
FDI Lab - SciCrunch.org
|
06/23/2020
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Limen of insula
|
The anterior basal part of the insular cortex, which separates the lateral surface of the insula from the anterior perforated substance (Heimer, The Human Brain and Spinal Cord, 2nd ed., 1995, pg 80).
|
ILX:0106266
|
10
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limitans nucleus
|
'Limitans nucleus' is a nucleus of brain.
|
ILX:0106267
|
11
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limulidae
|
|
ILX:0106268
|
5
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limulus
|
any horseshoe crab of the genus Limulus
|
ILX:0106269
|
5
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Limulus polyphemus
|
|
ILX:0106270
|
5
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Lincomycin
|
An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. (PubChem) Pharmacology: Lincomycin is a lincosamide antibiotic that comes from the yeast Streptomyces lincolnensis. Lincomycin has been shown to be active in vitro against the following microorganisms: Aerobic gram-positive cocci: Streptococcus pyogenes and Viridans group streptococci; Aerobic gram-positive bacilli: Corynebacterium diphtheriae; Anaerobic gram-positive non-sporeforming bacilli: Propionibacterium acnes; Anaerobic gram-positive sporeforming bacilli: Clostridium tetani and Clostridium perfringens. Mechanism of action: Lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50 S subunits of bacterial ribosomes and preventing peptide bond formation. It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible organisms. Drug type: Approved. Small Molecule. Drug category: Anti-Bacterial Agents. Lincomycins. Protein Synthesis Inhibitors
|
ILX:0106271
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Lindane
|
An organochlorine insecticide that has been used as a pediculicide and a scabicide. It has been shown to cause cancer. (PubChem) Pharmacology: Scabies is a common, highly pruritic infestation of the skin caused by Sarcoptes scabiei (lice). It is a very contagious condition with specific lesions, such as burrows, and nonspecific lesions, such as papules, vesicles and excoriations. The typical areas of the body it affects are finger webs, scalp (hair), wrists, axillary folds, abdomen, buttocks, inframammary folds and genitalia (males). It is characterized by intense night-time itching. Scabies is spread through close personal contact (relatives, sexual partners, schoolchildren, chronically ill patients and crowded communities). Scabies infestations and the corresponding symptoms can be eliminated by killing the scabies with topical insecticides or scabicides. Lindane is a scabicide that is essentially and organochloride insecticide. Mechanism of action: Lindane is an organochloride insecticide that exerts its parasiticidal action by being directly absorbed into the parasites (primarily lice, or scabies) and their ova. The gamma-aminobutyric acid (GABA(1)) receptor/chloride ionophore complex is the primary site of action for lindane, and other insecticides such as endosulfan, and fipronil. Blockage of the GABA-gated chloride channel reduces neuronal inhibition, which leads to hyperexcitation of the central nervous system, convulsions, and death. Drug type: Approved. Small Molecule. Drug category: Antiscabies Agent. Insecticides. Scabicide
|
ILX:0106272
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Linear
|
Narrow, with the two opposite margins parallel.
|
ILX:0106273
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Linear density
|
A linear quality which is equal to the mass exerting an influence on a one-dimensional object.
|
ILX:0106274
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Linear nucleus
|
'Linear nucleus' is a brainstem nucleus and midbrain nucleus. It is part of the midbrain tegmentum.
|
ILX:0106275
|
11
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Linear nucleus of the medulla of ABA 2009
|
|
ILX:0106276
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Linezolid
|
Linezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). The drug works by inhibiting the initiation of bacterial protein synthesis. Pharmacology: Linezolid is a synthetic antibacterial agent of a new class of antibiotics, the oxazolidinones, which has clinical utility in the treatment of infections caused by aerobic Gram-positive bacteria. The in vitro spectrum of activity of linezolid also includes certain Gram-negative bacteria and anaerobic bacteria. Susceptible organisms include methicillin- and vancomycin-resistant staphylococci, vancomycin-resistant enterococci, penicillin-resistant pneumococci and anaerobes. Oxazolidinones inhibit protein synthesis by binding at the P site at the ribosomal 50S subunit. Resistance to other protein synthesis inhibitors does not affect oxazolidinone activity, however rare development of oxazolidinone resistance cases, associated with 23S rRNA alterations during treatment have been reported. Linezolid inhibits bacterial protein synthesis through a mechanism of action different from that of other antibacterial agents; therefore, cross-resistance between linezolid and other classes of antibiotics is unlikely. Mechanism of action: Linezolid is a synthetic antibacterial agent of the oxazolidinone class of antibiotics. It has in vitro activity against aerobic Gram positive bacteria, certain Gram negative bacteria and anaerobic microorganisms. It selectively inhibits bacterial protein synthesis through binding to sites on the bacterial ribosome and prevents the formation of a functional 70S-initiation complex. Specifically, linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process. The results of time-kill studies have shown linezolid to be bacteriostatic against enterococci and staphylococci. For streptococci, linezolid was found to be bactericidal for the majority of strains. Linezolid is also a reversible, nonselective inhibitor of monoamine oxidase. Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents. Drug type: Approved. Investigational. Small Molecule. Drug category: Anti-Infective Agents. Antibacterial Agents. Protein Synthesis Inhibitors
|
ILX:0106277
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Lingual gyrus
|
Component of the occipital lobe. The rostral boundary of the lingual gyrus was the posterior extent of the parahippocampal gyrus whereas the caudal boundary was the most posterior coronal slice where the gyrus could be visualized. The medial and lateral boundaries were the medial portion of the temporal and occipital cortices and the medial bank of the collateral sulcus respectively (Christine Fennema-Notestine).
|
ILX:0106278
|
10
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Lingual papilla
|
|
ILX:0106279
|
11
|
FDI Lab - SciCrunch.org
|
06/23/2020
|
FDI Lab - SciCrunch.org |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |